New drug to stop 'Ozempic butt' muscle loss side effect of obesity jabs
A third of the weight loss from obesity jabs can come from muscle, say experts.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"The findings were promising but should be viewed as 'encouraging early evidence' rather than definitive proof of clinical benefit."
— Dr Marie Spreckley , Academic
"The treatment might not be suitable for everyone on GLP-1 drugs, but might help some who are losing muscle mass particularly fast."
— Dr Brendan Gabriel , Academic
Key People
Tags
All Coverage
A third of the weight loss from obesity jabs can come from muscle, say experts.
Researchers are developing a new medication to combat muscle loss associated with popular weight loss injections, as up to one-third of weight reduction from obesity jabs comes from muscle tissue.
A new muscle growth drug called apitegromab significantly reduced lean tissue loss for patients using GLP-1 slimming jabs during a 24-week clinical trial, allowing patients to retain 55% more muscle mass compared to those receiving a placebo.
A new drug called apitegromab could help people on obesity jabs avoid unwanted muscle decline that’s been linked to flat bums or “Ozempic butt”, according to research in the Nature Medicine journal.
Researchers are developing a new medication to combat muscle loss associated with popular weight loss injections. Experts say up to one-third of weight reduction from obesity jabs comes from muscle tissue.
A new muscle growth drug called apitegromab significantly reduced lean tissue loss for patients using GLP-1 slimming jabs during a 24-week clinical trial published in Nature Medicine on June 8, 2026.
A new drug called apitegromab could help people on obesity jabs avoid unwanted muscle decline that's been linked to flat bums or 'Ozempic butt', according to research in Nature Medicine journal.
A new drug called apitegromab could help people on obesity jabs avoid unwanted muscle decline that's been linked to flat bums or 'Ozempic butt', according to research in Nature Medicine journal.
Similar Stories
Related coverage based on topic and tags
Weight-loss drug Wegovy to be available in pill form in UK for first time
Manufacturer Novo Nordisk says a daily tablet of the drug could be more convenient for some people than weekly injections.
June 11, 2026 at 03:00 PMUK approves Novo weight-loss pill to edge open European market - Reuters
UK approves Novo weight-loss pill to edge open European market Reuters
June 11, 2026 at 08:22 PMHow do weight-loss drugs like Mounjaro and Wegovy work?
Wegovy and Mounjaro are available to certain patients on the NHS, and can also be bought privately.
June 11, 2026 at 03:03 PM'I've never been this good' – revolutionary immune reset puts lupus in remission
Patients on the trial have not needed medication to manage their condition.
June 11, 2026 at 11:31 PMNovo Nordisk flags patient data breach from some clinical trials in cyberattack - Reuters
Novo Nordisk flags patient data breach from some clinical trials in cyberattack Reuters
June 11, 2026 at 09:55 PMSidelined US research on alcohol's health effects published in independent journal - Reuters
Sidelined US research on alcohol's health effects published in independent journal Reuters
June 9, 2026 at 09:47 PM